Immunochemotherapy with Corynebacterium parvum in disseminated cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D002283:Carcinoma, Bronchogenic / Q000276:immunology / Q000628:therapy; D018288:Carcinoma, Small Cell / Q000276:immunology / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000276:immunology / Q000628:therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D011425:Propionibacterium acnes / Q000276:immunology*; D012882:Skin Tests
D000970:Antineoplastic Agents